Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01235169
Other study ID # WEIL02-HMO-CTIL
Secondary ID
Status Not yet recruiting
Phase Phase 1/Phase 2
First received November 4, 2010
Last updated March 21, 2013

Study information

Verified date March 2013
Source Hadassah Medical Organization
Contact Yoram Weil
Phone 972-2-6776342
Email weily@hadassah.org.il
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Interventional

Clinical Trial Summary

This is an open multicenter study, evaluating a new operative technique in femur neck fractures. The treatment consist of augmentated nails in cases of subtrochanteric or inter fracture due to osteoporosis.There two routine surgical techniques in femoral neck fractures:

1. Insertion an intramedullary nail (without augmentation) to the bone.

2. insertion a nail and metal plateto the bone. The major disadvantage of these methods is the relative high rate (4-10 precentages) of failure because of the femur head bone which is very brittle and osteoporotic.

This new approach enables the nail a better grip as a result of the cement augmentation which consists of PMMA (Polymethyl methacrylate).

The investigators main goal is to evaluate the use of this surgical technique


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 0
Est. completion date
Est. primary completion date March 2015
Accepts healthy volunteers No
Gender Both
Age group 60 Years to 90 Years
Eligibility Inclusion Criteria:

- PFNA augmentation is indicated for severe osteoporotic fractures (Subtrochanteric or intertrochanteric) in the proximal femur.

- Men and women above 80 years old that fuffer from fracture in the proximal femur.

Exclusion Criteria:

- Patient can not come to the follow up clinic visits.

Study Design

Intervention Model: Single Group Assignment, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Proximal Femoral Nail Antirotation(PFNA) with cement augmentation


Locations

Country Name City State
Israel Hadassah Medical Organizaton Jerusalem

Sponsors (1)

Lead Sponsor Collaborator
Hadassah Medical Organization

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of patients reaching union at the 3-month and 6-month follow up Proportion of patients reaching union at the 3-month and 6-month follow up will be assessed. Union is defined by both clinical evaluation-pain and weight bearing status, and radiological evaluation- three out of four cortices must be bridged as viewed on plain X-ray (AP and lateral views).
See also
  Status Clinical Trial Phase
Recruiting NCT05920642 - Postoperative Pain Relieve for Patients Undergoing Surgical Treatment of Femoral Fracture Phase 4
Recruiting NCT04309539 - Which Analgesia is Better for Proximal Femoral Fractures? N/A
Completed NCT01435538 - European Quality of Care Pathways Study on the Effect of Care Pathways on Interprofessional Teamwork (EQCP-TEAM) N/A
Not yet recruiting NCT06396884 - Hemodynamic Optimization During Spinal Anesthesia in the Elderly
Terminated NCT01035177 - In Vivo Hip Fracture Discrimination With Quantitative Computed Tomography (QCT) N/A
Completed NCT05091359 - Femur Transtrochanteric Fractures Treated With Dynamic Hip Screw and Calcium Sulfate Scaffold. N/A